Variant report

Variant	nsv1027355
Chromosome Location	chr6:20207893-20261048
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:870)
CpG islands
(count:857)
Chromatin interactive
region (count:69)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:870 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:20213207-20214140	K562	blood:	n/a	n/a
2	ATF1	chr6:20227623-20227908	K562	blood:	n/a	n/a
3	ATF1	chr6:20217050-20217130	K562	blood:	n/a	n/a
4	ATF1	chr6:20243622-20243739	K562	blood:	n/a	n/a
5	ATF2	chr6:20212045-20212627	GM12878	blood:	n/a	n/a
6	ATF2	chr6:20208854-20209313	GM12878	blood:	n/a	n/a
7	ATF2	chr6:20212757-20213399	GM12878	blood:	n/a	n/a
8	ATF3	chr6:20212782-20213274	K562	blood:	n/a	chr6:20212880-20212900
9	BACH1	chr6:20212621-20212719	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr6:20212986-20213178	H1-hESC	embryonic stem cell:	n/a	n/a
11	BATF	chr6:20208961-20209288	GM12878	blood:	n/a	chr6:20209184-20209195
12	BATF	chr6:20208994-20209324	GM12878	blood:	n/a	chr6:20209184-20209195
13	BCL3	chr6:20212385-20212895	GM12878	blood:	n/a	n/a
14	BHLHE40	chr6:20217769-20217940	K562	blood:	n/a	n/a
15	BHLHE40	chr6:20216898-20217269	K562	blood:	n/a	n/a
16	BHLHE40	chr6:20221704-20222033	K562	blood:	n/a	n/a
17	BHLHE40	chr6:20209059-20209259	GM12878	blood:	n/a	n/a
18	BHLHE40	chr6:20211314-20211804	K562	blood:	n/a	n/a
19	BHLHE40	chr6:20212038-20213585	GM12878	blood:	n/a	chr6:20212884-20212900 chr6:20212757-20212773 chr6:20212887-20212903
20	BHLHE40	chr6:20212129-20214104	K562	blood:	n/a	chr6:20212884-20212900 chr6:20212757-20212773 chr6:20212887-20212903
21	BRCA1	chr6:20212673-20213405	Hela-S3	cervix:	n/a	n/a
22	CBX3	chr6:20212086-20214199	K562	blood:	n/a	n/a
23	CCNT2	chr6:20212218-20213223	K562	blood:	n/a	n/a
24	CCNT2	chr6:20213749-20214173	K562	blood:	n/a	n/a
25	CEBPB	chr6:20213596-20214043	K562	blood:	n/a	n/a
26	CEBPB	chr6:20213707-20213875	Hela-S3	cervix:	n/a	n/a
27	CEBPB	chr6:20250052-20250365	HepG2	liver:	n/a	chr6:20250207-20250218
28	CEBPB	chr6:20250154-20250259	A549	lung:	n/a	chr6:20250207-20250218
29	CEBPB	chr6:20255822-20256001	K562	blood:	n/a	chr6:20255856-20255867 chr6:20255858-20255867 chr6:20255858-20255869
30	CEBPB	chr6:20213574-20214008	K562	blood:	n/a	n/a
31	CEBPB	chr6:20225855-20226116	HepG2	liver:	n/a	chr6:20225986-20225997
32	CEBPB	chr6:20225871-20226072	K562	blood:	n/a	chr6:20225986-20225997
33	CEBPB	chr6:20227593-20227927	K562	blood:	n/a	n/a
34	CEBPB	chr6:20227659-20227932	K562	blood:	n/a	n/a
35	CEBPB	chr6:20211419-20212312	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr6:20256862-20257065	K562	blood:	n/a	n/a
37	CEBPB	chr6:20255730-20255991	HepG2	liver:	n/a	chr6:20255856-20255867 chr6:20255858-20255867 chr6:20255858-20255869
38	CEBPB	chr6:20212588-20213370	Hela-S3	cervix:	n/a	n/a
39	CEBPD	chr6:20235221-20235726	K562	blood:	n/a	n/a
40	CHD1	chr6:20212033-20213391	GM12878	blood:	n/a	chr6:20212928-20212935 chr6:20213019-20213029
41	CHD2	chr6:20211867-20213254	GM12878	blood:	n/a	chr6:20212928-20212935 chr6:20213019-20213029
42	CHD2	chr6:20209064-20209210	GM12878	blood:	n/a	n/a
43	CHD2	chr6:20211265-20211948	H1-hESC	embryonic stem cell:	n/a	n/a
44	CHD2	chr6:20212313-20213386	H1-hESC	embryonic stem cell:	n/a	chr6:20212928-20212935 chr6:20213019-20213029
45	CHD2	chr6:20212612-20213566	K562	blood:	n/a	chr6:20212928-20212935 chr6:20213019-20213029
46	CHD2	chr6:20211489-20213339	Hela-S3	cervix:	n/a	chr6:20212928-20212935 chr6:20213019-20213029
47	CREB1	chr6:20212437-20212635	A549	lung:	n/a	n/a
48	CREB1	chr6:20212641-20213129	A549	lung:	n/a	n/a
49	CTBP2	chr6:20212259-20213279	H1-hESC	embryonic stem cell:	n/a	n/a
50	CTCF	chr6:20212280-20212430	GM12873	blood:	n/a	n/a

(count:857 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:20211373-20211423	PrEC	prostate:	n/a
2	chr6:20212269-20212319	MCF10A-Er-Src	breast:	n/a
3	chr6:20233534-20233584	AG09309	skin:	n/a
4	chr6:20211373-20211423	PrEC	prostate:	n/a
5	chr6:20212269-20212319	MCF10A-Er-Src	breast:	n/a
6	chr6:20233534-20233584	AG09309	skin:	n/a
7	chr6:20211654-20211704	MCF-7	breast:	n/a
8	chr6:20211654-20211704	AG10803	skin:	n/a
9	chr6:20233534-20233584	HRCEpiC	kidney:	n/a
10	chr6:20239552-20239602	HEK293	kidney:	embryo
11	chr6:20233534-20233584	BE2_C	brain:	n/a
12	chr6:20239255-20239305	GM12891	blood:	n/a
13	chr6:20212978-20213028	HCPEpiC	choroid plexus:	n/a
14	chr6:20239552-20239602	HRE	kidney:	n/a
15	chr6:20233534-20233584	A549	lung:	n/a
16	chr6:20211373-20211423	BJ	skin:	n/a
17	chr6:20209127-20209177	LNCaP	prostate:	n/a
18	chr6:20233727-20233777	H1-hESC	embryonic stem cell:	embryo
19	chr6:20212269-20212319	SK-N-SH	brain:	n/a
20	chr6:20239552-20239602	HCF	heart:	n/a
21	chr6:20212269-20212319	HCM	heart:	n/a
22	chr6:20209127-20209177	AG10803	skin:	n/a
23	chr6:20211654-20211704	HepG2	liver:	n/a
24	chr6:20211654-20211704	ovcar-3	ovarian:	n/a
25	chr6:20233727-20233777	AG10803	skin:	n/a
26	chr6:20212978-20213028	HCT-116	colon:	n/a
27	chr6:20239552-20239602	IMR90	lung:	fetal
28	chr6:20212269-20212319	BE2_C	brain:	n/a
29	chr6:20215399-20215449	AG10803	skin:	n/a
30	chr6:20233534-20233584	HCT-116	colon:	n/a
31	chr6:20212667-20212717	NHDF-neo	bronchial:	n/a
32	chr6:20215399-20215449	Jurkat	blood:	n/a
33	chr6:20215399-20215449	PANC-1	pancreas:	n/a
34	chr6:20245292-20245342	HMEC	breast:	n/a
35	chr6:20212673-20212723	SK-N-SH_RA	brain:	n/a
36	chr6:20239552-20239602	MCF10A-Er-Src	breast:	n/a
37	chr6:20212269-20212319	AG09319	gingival:	n/a
38	chr6:20212269-20212319	IMR90	lung:	fetal
39	chr6:20233534-20233584	HepG2	liver:	n/a
40	chr6:20211654-20211704	HAEpiC	amniotic membrane:	n/a
41	chr6:20239552-20239602	Hela-S3	cervix:	n/a
42	chr6:20215399-20215449	NH-A	brain:	n/a
43	chr6:20239255-20239305	HEK293	kidney:	embryo
44	chr6:20215399-20215449	BJ	skin:	n/a
45	chr6:20233534-20233584	GM12892	blood:	n/a
46	chr6:20239255-20239305	BJ	skin:	n/a
47	chr6:20245186-20245236	GM19239	blood:	n/a
48	chr6:20233534-20233584	Caco-2	colon:	n/a
49	chr6:20212673-20212723	MCF-7	breast:	n/a
50	chr6:20212978-20213028	MCF10A-Er-Src	breast:	n/a

(count:69 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:20229285..20232940-chr6:20236537..20239101,3	K562	blood:
2	chr6:20250718..20252698-chr6:20267503..20269386,2	K562	blood:
3	chr6:20220736..20222285-chr6:20225586..20228558,2	MCF-7	breast:
4	chr6:20212250..20215196-chr6:20223985..20227837,5	K562	blood:
5	chr6:20238553..20240582-chr6:20241959..20245472,3	K562	blood:
6	chr6:20216776..20219690-chr6:20224982..20227317,2	MCF-7	breast:
7	chr6:20159507..20162340-chr6:20213634..20216190,2	MCF-7	breast:
8	chr6:20211909..20212822-chr6:20402314..20402881,2	Hela-S3	cervix:
9	chr6:20220736..20222285-chr6:20225586..20228558,2	MCF-7	breast:
10	chr6:20201120..20201764-chr6:20210706..20211232,2	MCF-7	breast:
11	chr13:111367198..111368071-chr6:20212805..20213310,2	Hela-S3	cervix:
12	chr6:20213363..20215491-chr6:20226675..20228588,2	MCF-7	breast:
13	chr1:205600773..205601519-chr6:20212511..20213215,2	NB4	blood:
14	chr6:20250024..20251861-chr6:20400909..20403842,3	K562	blood:
15	chr6:20249102..20251350-chr6:20252406..20254618,3	K562	blood:
16	chr6:20212542..20214233-chr6:20238029..20240822,2	MCF-7	breast:
17	chr20:52840503..52842605-chr6:20208710..20211532,2	MCF-7	breast:
18	chr6:17393765..17396443-chr6:20210532..20213161,2	MCF-7	breast:
19	chr6:20209069..20211986-chr6:20231381..20233005,2	K562	blood:
20	chr6:20250098..20251839-chr6:20259482..20261565,2	K562	blood:
21	chr6:20217096..20219531-chr6:20220543..20223261,2	MCF-7	breast:
22	chr6:20215918..20219378-chr6:20401289..20404111,5	K562	blood:
23	chr6:20227262..20229694-chr6:20256912..20259182,2	K562	blood:
24	chr6:20212162..20214669-chr6:20223184..20226435,3	K562	blood:
25	chr6:20200700..20201255-chr6:20210255..20211078,3	MCF-7	breast:
26	chr6:20254298..20256549-chr6:20402064..20404625,3	K562	blood:
27	chr6:20183085..20183879-chr6:20210423..20210990,2	MCF-7	breast:
28	chr6:20213974..20215520-chr9:92218381..92220552,2	MCF-7	breast:
29	chr6:20233971..20236766-chr6:20402526..20404050,2	MCF-7	breast:
30	chr6:20199116..20200755-chr6:20209336..20210921,2	K562	blood:
31	chr6:20230061..20232198-chr6:20234155..20236953,3	K562	blood:
32	chr6:20208250..20214334-chr6:20400294..20406447,14	K562	blood:
33	chr6:20211929..20216104-chr6:20227975..20231920,3	K562	blood:
34	chr6:20249185..20251861-chr6:20402342..20404972,2	K562	blood:
35	chr6:20126269..20128367-chr6:20209873..20212157,2	MCF-7	breast:
36	chr6:20117949..20119536-chr6:20206647..20209362,2	MCF-7	breast:
37	chr6:20235276..20236928-chr6:20238646..20240151,2	MCF-7	breast:
38	chr6:20233889..20236800-chr6:20238338..20241700,4	K562	blood:
39	chr6:20216776..20219690-chr6:20224982..20227317,2	MCF-7	breast:
40	chr6:20250098..20251839-chr6:20259482..20261565,2	K562	blood:
41	chr2:25300005..25301584-chr6:20210003..20211589,2	MCF-7	breast:
42	chr6:20257438..20259509-chr6:20267766..20269754,2	K562	blood:
43	chr6:20208057..20215931-chr6:20401288..20405953,13	MCF-7	breast:
44	chr6:20212989..20214883-chr6:20456758..20459141,2	K562	blood:
45	chr6:20214474..20216698-chr6:20404358..20407296,3	K562	blood:
46	chr6:20243580..20245382-chr6:20252186..20254509,2	K562	blood:
47	chr6:20211598..20216001-chr6:20216238..20220136,10	K562	blood:
48	chr6:20257163..20259345-chr6:20402768..20405752,2	K562	blood:
49	chr6:20255614..20258588-chr6:20259384..20261852,2	MCF-7	breast:
50	chr6:20213363..20215491-chr6:20226675..20228588,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-E2F3-2	chr6:20212318-20212408	ENSG00000227803.1
2	lnc-E2F3-2	chr6:20212318-20212408	ENSG00000227803.2

No data

Variant related genes	Relation type
MBOAT1	TF binding region
ENSG00000227803	TF binding region
MBOAT1	CpG island
ENSG00000227803	CpG island
ENSG00000112186	chromatin interactions
ENSG00000261360	chromatin interactions
ENSG00000158711	chromatin interactions
ENSG00000130222	chromatin interactions
ENSG00000075624	chromatin interactions
ENSG00000154124	chromatin interactions
ENSG00000227803	chromatin interactions
ENSG00000112242	chromatin interactions
ENSG00000172197	chromatin interactions
ENSG00000153487	chromatin interactions

Extended variants
information (count: 2356 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:2356 , 50 per page) page: 1 2 3 4 5 6 7 ... 48

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1536580	chr6:20207926-20207927	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs544984704	chr6:20207960-20207961	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs562238058	chr6:20208011-20208012	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs530450697	chr6:20208045-20208046	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs12174217	chr6:20208088-20208089	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs190246035	chr6:20208092-20208093	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs372132995	chr6:20208099-20208100	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs546812900	chr6:20208106-20208107	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs571373971	chr6:20208123-20208124	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs12204103	chr6:20208124-20208125	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs550690970	chr6:20208198-20208199	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs139579267	chr6:20208317-20208318	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs183351318	chr6:20208318-20208319	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs187792679	chr6:20208378-20208379	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs567448293	chr6:20208390-20208391	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs534778001	chr6:20208400-20208401	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs115446747	chr6:20208405-20208406	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs577944798	chr6:20208455-20208456	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs191066009	chr6:20208506-20208507	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs549650594	chr6:20208533-20208534	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs182526400	chr6:20208534-20208535	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs375133876	chr6:20208552-20208553	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs188067229	chr6:20208594-20208595	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs371982188	chr6:20208608-20208609	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs528776438	chr6:20208609-20208610	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs76796733	chr6:20208644-20208645	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs533376704	chr6:20208668-20208669	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs10527757	chr6:20208676-20208677	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs74329833	chr6:20208684-20208685	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs61111658	chr6:20208687-20208688	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs57928532	chr6:20208688-20208689	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs555579656	chr6:20208720-20208721	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs369235776	chr6:20208729-20208730	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs567914605	chr6:20208749-20208750	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs192442477	chr6:20208818-20208819	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs532615850	chr6:20208877-20208878	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs535454348	chr6:20208886-20208887	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs569264945	chr6:20208920-20208921	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs112710742	chr6:20208922-20208923	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs9368157	chr6:20208926-20208927	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs149732446	chr6:20208936-20208937	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs371742783	chr6:20209003-20209004	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs556965195	chr6:20209070-20209071	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs75511078	chr6:20209072-20209073	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs376120526	chr6:20209128-20209129	Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs534897821	chr6:20209138-20209139	Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs183146778	chr6:20209192-20209193	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs34977519	chr6:20209222-20209223	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs571462860	chr6:20209258-20209259	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs77417538	chr6:20209303-20209304	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	16790693	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial cell carcinoma	18451213	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Ovarian cancer	20844748	CNVD
Developmental delay	19490664	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Lung cancer	19153074	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:1087 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:20193000-20209200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr6:20199400-20210000	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr6:20200600-20209200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr6:20201400-20210800	Weak transcription	Fetal Stomach	stomach
5	chr6:20201800-20209000	Weak transcription	Fetal Lung	lung
6	chr6:20202600-20211200	Enhancers	Stomach Mucosa	stomach
7	chr6:20203200-20210400	Weak transcription	Fetal Kidney	kidney
8	chr6:20203200-20211200	Weak transcription	Liver	Liver
9	chr6:20203200-20211200	Weak transcription	NHDF-Ad	bronchial
10	chr6:20203600-20208000	Enhancers	Rectal Smooth Muscle	rectum
11	chr6:20203600-20210400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr6:20203800-20208200	Enhancers	Ovary	ovary
13	chr6:20204000-20208200	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr6:20204400-20210000	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr6:20204400-20210400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr6:20204600-20208800	Weak transcription	Stomach Smooth Muscle	stomach
17	chr6:20204600-20211000	Weak transcription	HMEC	breast
18	chr6:20204600-20211200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr6:20204600-20211200	Weak transcription	A549	lung
20	chr6:20204800-20210000	Weak transcription	HUES48 Cell Line	embryonic stem cell
21	chr6:20204800-20211200	Enhancers	Fetal Heart	heart
22	chr6:20205000-20211200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr6:20205200-20209600	Weak transcription	NHEK	skin
24	chr6:20205200-20210000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr6:20205400-20210000	Weak transcription	Left Ventricle	heart
26	chr6:20205600-20208200	Enhancers	iPS-20b Cell Line	embryonic stem cell
27	chr6:20205800-20208200	Enhancers	K562	blood
28	chr6:20206000-20208200	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr6:20206200-20209600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr6:20206400-20209000	Weak transcription	Sigmoid Colon	Sigmoid Colon
31	chr6:20206400-20210000	Weak transcription	H1 Cell Line	embryonic stem cell
32	chr6:20206400-20210000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr6:20206400-20210000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr6:20206400-20210000	Weak transcription	Gastric	stomach
35	chr6:20206400-20211200	Weak transcription	Fetal Muscle Leg	muscle
36	chr6:20206400-20211200	Weak transcription	Pancreas	Pancrea
37	chr6:20206600-20208000	Flanking Active TSS	GM12878-XiMat	blood
38	chr6:20206600-20211200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr6:20206800-20211200	Weak transcription	Placenta	Placenta
40	chr6:20206800-20211400	Weak transcription	Skeletal Muscle Male	skeletal muscle
41	chr6:20207000-20210000	Weak transcription	Adipose Nuclei	Adipose
42	chr6:20207000-20210000	Weak transcription	Colonic Mucosa	Colon
43	chr6:20207000-20210000	Weak transcription	Esophagus	oesophagus
44	chr6:20207200-20209400	Enhancers	Colon Smooth Muscle	Colon
45	chr6:20207200-20210000	Weak transcription	Lung	lung
46	chr6:20207200-20211200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr6:20207200-20211200	Weak transcription	Spleen	Spleen
48	chr6:20207400-20208200	Enhancers	Duodenum Smooth Muscle	Duodenum
49	chr6:20207400-20211200	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr6:20207600-20208000	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links